FDA Import Refusal 1FX-2200196-9/10002/1 — Biopharm Australia Pty. Ltd.
The FDA refused shipment 1FX-2200196-9/10002/1 from Biopharm Australia Pty. Ltd. (Australia) on March 24, 2026. The refused product falls under Drugs and Biologics — PENTOSAN POLYSULFATE SODIUM (URICOSURIC). Cited charge: 72 This firm has 3 other import refusals on record.
Refusal Details
- Date
- March 24, 2026
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 66QQK10 PENTOSAN POLYSULFATE SODIUM (URICOSURIC)
- Charges
- 72